BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Aug 01, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

OncoVEX GM-CSF: Phase III discontinued

Amgen stopped a Phase III trial of OncoVEX GM-CSF to treat SCCHN. Amgen did not disclose how many of the expected 500 patients had been enrolled in the trial. The company said it plans...

Read the full 148 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >